Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.11% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
FEED · Mar 31, 2024
ENvue Medical, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001493152-24-019675General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-62.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
160.17% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
281.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
72.10% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-61.67% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.14% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
11.62% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20247/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20256/8 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.04%
- Current
- 0.11%
- Delta
- 0.06%
- Previous
- -157.77%
- Current
- -62.87%
- Delta
- 94.91%
- Previous
- 203.59%
- Current
- 160.17%
- Delta
- -43.42%
- Previous
- 119.67%
- Current
- 281.00%
- Delta
- 161.33%
- Previous
- 67.32%
- Current
- 72.10%
- Delta
- 4.77%
- Previous
- -150.50%
- Current
- -61.67%
- Delta
- 88.83%
- Previous
- 8.10%
- Current
- 13.14%
- Delta
- 5.03%
- Previous
- 12.83%
- Current
- 11.62%
- Delta
- -1.22%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · FEED Fundamental State →Has State · ENvue Medical, Inc. →Transitioned To · FEED Fundamental State →Transitioned To · FEED CAPEX_INTENSITY_INCREASED →Transitioned To · FEED CASH_GENERATION_INCREASED →Transitioned To · FEED GROWTH_DECREASED →Transitioned To · FEED INVENTORY_PRESSURE_INCREASED →Transitioned To · FEED MARGIN_INCREASED →Transitioned To · FEED PROFITABILITY_INCREASED →Transitioned To · FEED R_AND_D_INTENSITY_INCREASED →Transitioned To · FEED SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.